Noliterax (Indapamide, Perindopril Arginine)

Indapamide, the active ingredient in Noliterax, is a thiazide-like diuretic and ACE inhibitor combination presented as an oral tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Noliterax as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noliterax is an antihypertensive medication that works within the renin‑angiotensin‑aldosterone system and renal sodium handling pathways. - Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Heart failure: assists in blood‑pressure control as part of a physician‑directed regimen for patients with heart failure. - Diabetic nephropathy: helps achieve target blood pressure in patients with diabetes, supporting renal protection.

Noliterax may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Persistent dry cough - Increased urinary frequency - Electrolyte disturbances (e.g., low potassium) - Fatigue or weakness

Serious or Rare Side Effects: - Severe hypotension - Angioedema (swelling of face, lips, tongue) - Hyperkalemia - Acute renal impairment - Pancreatitis - Blood dyscrasias such as agranulocytosis

Before initiating Noliterax, several safety considerations should be observed. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Renal function assessment: evaluate serum creatinine and eGFR prior to use. - Electrolyte checks: monitor potassium and sodium levels regularly. - Contraindication in severe renal impairment: avoid if eGFR is markedly reduced. - Caution with potassium‑sparing agents: risk of hyperkalemia. - Allergy to ACE inhibitors: discontinue if angioedema occurs. - Store at ambient temperature: keep in the original container, protect from moisture.

Noliterax can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Aliskiren in diabetic patients: increased risk of renal dysfunction. - Potassium supplements or high‑potassium diet: may cause hyperkalemia. - NSAIDs (e.g., ibuprofen, naproxen): can diminish antihypertensive effect and impair renal function. - Lithium: risk of lithium toxicity due to reduced clearance. - Other potent diuretics: may lead to severe electrolyte imbalance.

Moderate Interactions (Monitor Closely): - ARBs or other ACE inhibitors: additive blood‑pressure lowering effect. - Beta‑blockers: may enhance hypotensive response. - Thiazide diuretics: monitor electrolytes closely. - Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole): can increase potassium levels. - Glucocorticoids: may counteract antihypertensive effect.